Related Experiment Video
Updated: Sep 8, 2025

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Understanding lived experiences with KCNQ2 developmental and epileptic encephalopathy
Michele H Potashman1, Katja Rudell2, Linda Abetz-Webb3
1Biohaven Pharmaceuticals, Inc., New Haven, CT, USA.
Insights
KCNQ2 developmental and epileptic encephalopathy (KCNQ2-DEE) significantly impacts communication and motor skills in children. Parent and healthcare provider input is crucial for developing effective outcome measures for this rare pediatric disorder.
Area of Science:
- Genetics and Neurology
- Pediatric Rare Diseases
- Clinical Outcome Measurement
Background:
- KCNQ2 developmental and epileptic encephalopathy (KCNQ2-DEE) is a severe pediatric neurological disorder.
- Characterized by early-onset seizures and significant neurodevelopmental impairments.
- Existing outcome measures may not fully capture the patient and family experience.
Purpose of the Study:
- To explore parent and healthcare professional (HCP) perspectives on KCNQ2-DEE.
- Identify key signs, symptoms, and impacts of KCNQ2-DEE.
- Inform the development of meaningful outcome measures for KCNQ2-DEE.
Main Methods:
- Qualitative interviews conducted with 53 parents of children with KCNQ2-DEE and 2 expert HCPs.
- Interviews explored signs, symptoms, impacts, and phenotypic variations affecting development.
- Data analyzed using ATLAS.Ti v23 software.
Main Results:
- Parents most frequently reported communication difficulties (88.9%) and motor problems (gross 81.5%, fine 63.0%).
- Communication difficulties (74.1%), behavioral disorders (37.0%), and gross motor problems (24.1%) were most bothersome.
- Seizures were less bothersome post-infancy (mean score 5.3/10); developmental abilities varied significantly.
Conclusions:
- Parent and HCP perspectives highlight communication and motor skills as critical outcome domains in KCNQ2-DEE.
- Findings underscore the need for patient-centered outcome measures.
- Results will guide the selection of endpoints in future KCNQ2-DEE therapeutic trials.
Background:
KCNQ2 developmental and epileptic encephalopathy (KCNQ2-DEE) is a rare pediatric disorder characterized by seizures and neurodevelopmental impairments. Parent- and healthcare professional (HCP)-reported outcomes regarding the impacts of seizures and neurodevelopmental impairments may guide the design of clinically meaningful KCNQ2-DEE outcome measures.
Methods:
Parents of children with KCNQ2-DEE (N = 53) and HCPs with KCNQ2-DEE expertise (N = 2) participated in qualitative interviews exploring signs, symptoms, and impacts of KCNQ2-DEE, and how varying KCNQ2-DEE phenotypes affect child development. Interviews were recorded, transcribed, coded, and analyzed by ATLAS.Ti v23 software.
Results:
The most common KCNQ2-DEE concepts parents reported were difficulties with communication (88.9 %), and gross (81.5 %) and fine (63.0 %) motor problems. Difficulty with communication (74.1 %), behavioral disorders (37.0 %), and gross motor problems (24.1 %) were the most impactful and bothersome issues for parents. When asked to rate how impacted they were by each concept (0 = "not impacted" to 10 = "extremely impacted"), the most bothersome symptoms were difficulty with communication (mean score [SD] = 8.6 [1.7]; 87.0 % of parents), cognitive delays (8.1 [2.0]; 37.0 % parents), and personal care and hygiene issues (7.4 [2.2]; 29.6 % parents). Seizures were the least bothersome symptom post-infancy (mean score [SD] = 5.3 [3.6]; 87.0 % parents). Children's developmental abilities varied substantially within and between KCNQ2-DEE phenotypes and across age groups. Overall, HCPs reported largely similar concepts to parents of children with KCNQ2-DEE.
Conclusions:
These findings identify outcome domains important to those with KCNQ2-DEE and may inform the development of measurement tools and endpoint selection for therapeutic trials.
More Related Videos
11:54Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
Published on: January 29, 2018
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types: